首页> 外文OA文献 >Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate

【2h】

Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate

机译：与利塞膦酸盐或伊班膦酸盐相比，绝经后妇女转为地诺单抗的双膦酸盐亚最佳依从性高

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Palacios, S.; Agodoa, I.; Bonnick, S.; van den Bergh, J.; Ferreira, I.; Ho, P.R.; Brown, J.P.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate [J] . BrownJ.P., RouxC., HoP.R., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2014,第7期

机译：与绝经后妇女相比，尽管先前曾接受口服双膦酸盐的次优治疗，但骨折风险仍然较高的绝经后妇女与每月口服伊班膦酸钠和利塞膦酸盐相比，地诺单抗显着增加了骨矿物质密度并减少了骨转换
2. Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate [J] . BrownJ.P., RouxC., HoP.R., Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . 2014,第7期

机译：Deaosumab显着提高骨矿物质密度，并与每月口腔母母母母植物和日期前孕妇中的骨头植物和日式疗法减少骨质营业额，尽管以口服双膦酸盐次次替次替代治疗较高的裂缝风险
3. Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study [J] . RouxC., HofbauerL.C., HoP.R., Bone . 2014,第Null期

机译：在绝经后坚持阿仑膦酸盐治疗的绝经后妇女中，Denosumab与Rucedronate的比较：一项随机开放标签研究的疗效和安全性
4. Effects of Resistance Exercise Compared to Weight-Bearing Aerobic Exercise on Bone Mineral Density, Fall Risk, and Quality of Life for Postmenopausal Women with Low Bone Mass: A Meta-Analysis [D] . Kwon, Diane. 2020

机译：抗性运动对骨密度，下降风险和低骨质妇女的骨密度，落下风险和生活质量相比的影响：META分析
5. Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q™) a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women [O] . Emuella M Flood, Kathleen M Beusterien, Hannah Green, 2006

机译：骨质疏松症患者治疗满意度问卷（OPSAT-Q™）的心理计量学评估这是一种评估绝经后妇女对双膦酸盐治疗满意度的新方法
6. Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study [O] . C. Roux, L.C. Hofbauer, P.R. Ho, 2014

机译：在绝经后坚持阿仑膦酸钠治疗的绝经后妇女中，Denosumab与Risedronate的比较：一项随机开放标签研究的疗效和安全性

Treatment satisfaction in postmenopausal women suboptimally adherent to bisphosphonates who transitioned to denosumab compared with risedronate or ibandronate

著录项

相似文献

相关主题

期刊订阅